D

AgomAb Therapeutics Series C

Dated company PDF confirms $100m Series C close led by Fidelity.

Suggest an update

USD 100,000,000 AmountOct 11, 2023 Announced

Source evidence

Agomab Raises $100 Million Series C to Advance Fibrosis-focused Pipeline · agomab01-a405198c5a-abf8c4eyf4e4gace.z02.azurefd.net ↗

Something wrong or missing? Send an update. Fixed within 24 hours.